|
|
|
Insider
Information: |
Goldberg David C |
Relationship: |
Chief Operating Officer |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
121,367 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$103,906 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
121,367 |
|
|
Total
Value |
$103,906 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Enzo Biochem Inc |
ENZ |
VP CorpDev IGM Enz Cl... |
2012-01-26 |
87,316 |
2004-08-10 |
0 |
Premium* |
|
Authentidate Holding Corp |
ADAT |
Chief Operating Officer |
2017-11-17 |
34,051 |
2017-09-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ADAT |
Authentidate Holding Corp |
Chief Operating Officer |
|
2017-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
32,051 |
32,051 |
0 |
- |
|
ADAT |
Authentidate Holding Corp |
Chief Operating Officer |
|
2017-11-17 |
4 |
B |
$0.55 |
$1,100 |
D/D |
2,000 |
34,051 |
2.66 |
- |
|
ENZ |
Enzo Biochem Inc |
VP, Business Development |
|
2005-05-26 |
4 |
OE |
$6.84 |
$48,119 |
D/D |
7,035 |
35,402 |
|
- |
|
ENZ |
Enzo Biochem Inc |
VP, Business Development |
|
2005-05-26 |
4/A |
OE |
$6.84 |
$48,119 |
D/D |
7,035 |
35,658 |
|
- |
|
ENZ |
Enzo Biochem Inc |
VP, Corporate Development |
|
2010-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
67,272 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
Vice President, Bus. Dev. |
|
2004-08-10 |
4 |
OE |
$7.28 |
$24,375 |
D/D |
3,350 |
73,628 |
|
- |
|
ENZ |
Enzo Biochem Inc |
VP CorpDev IGM Enz Clin Labs |
|
2012-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
87,316 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
VP, Business Development |
|
2007-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,118 |
94,391 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
VP, Business Development |
|
2008-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
94,391 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
VP, Business Development |
|
2007-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,191 |
99,654 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
VP, Business Development |
|
2008-09-23 |
4 |
D |
$11.26 |
$33,127 |
D/D |
(2,942) |
103,605 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
VP, Business Development |
|
2008-09-23 |
4 |
OE |
$5.45 |
$33,125 |
D/D |
6,078 |
106,547 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
VP, Business Development |
|
2006-07-30 |
4 |
OE |
$10.63 |
$71,221 |
D/D |
6,700 |
107,017 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
VP, Business Development |
|
2007-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
896 |
108,116 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
VP, Corporate Development |
|
2009-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
110,547 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
Vice President, Business Devel |
|
2004-12-10 |
5 |
OE |
$7.11 |
$39,998 |
D/D |
5,628 |
113,031 |
0 |
- |
|
ENZ |
Enzo Biochem Inc |
VP CorpDev Pres Enz Clin Labs |
|
2011-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
123,934 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|